City Therapeutics
$135.0M
Funding date
Valuation / Funding
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| October 8, 2024 | Early Stage VC (Series A) | $135.0M | N/A | - |
Current Valuation Metrics
City Therapeutics is currently valued at $285.5M as of October 8, 2024. The company has raised a total of $139.5M in funding across 1 funding round.
Capital Efficiency
With a capital efficiency ratio of 2.05x, City Therapeutics has achieved a valuation that is 2.05 times the total capital raised.
What is City Therapeutics Worth in 2026?
City Therapeutics is a leading private company in the Drug Discovery sector. Track City Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How City Therapeutics Valuation is Determined
Private company valuations like City Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.